Camp4 Therapeutics (CAMP) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to 0.68.
- Camp4 Therapeutics' Equity Ratio rose 10912.55% to 0.68 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68, marking a year-over-year increase of 10912.55%. This contributed to the annual value of 0.81 for FY2024, which is 13580.9% up from last year.
- Per Camp4 Therapeutics' latest filing, its Equity Ratio stood at 0.68 for Q3 2025, which was up 10912.55% from 0.78 recorded in Q2 2025.
- Over the past 5 years, Camp4 Therapeutics' Equity Ratio peaked at 0.82 during Q1 2025, and registered a low of 7.44 during Q3 2024.
- Moreover, its 3-year median value for Equity Ratio was 0.73 (2025), whereas its average is 1.1.
- As far as peak fluctuations go, Camp4 Therapeutics' Equity Ratio soared by 13580.9% in 2024, and later soared by 10912.55% in 2025.
- Quarter analysis of 3 years shows Camp4 Therapeutics' Equity Ratio stood at 2.25 in 2023, then surged by 135.81% to 0.81 in 2024, then decreased by 15.79% to 0.68 in 2025.
- Its Equity Ratio was 0.68 in Q3 2025, compared to 0.78 in Q2 2025 and 0.82 in Q1 2025.